Gero raises $34M to advance physics-first aging medicines (opens in new tab)

Gero announced $17 million in new financing, bringing total equity funding to $34 million to advance its physics-first AI drug discovery platform for aging and age-related diseases. The financing follows a collaboration with Chugai Pharmaceutical, a Roche Group member, that includes an upfront payment and up to $250 million in milestone payments plus royalties; under […] The post appeared first on <a href="